ArticleScientific reports2016

The chimeric ubiquitin ligase SH2-U-box inhibits the growth of imatinib-sensitive and resistant CML by targeting the native and T315I-mutant BCR-ABL.

Yi Ru et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.